The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
PAXG versus (m)FOLFIRINOX as first-Line therapy for unresectable locally advanced or metastatic pancreatic cancer: A real-world, propensity-weighted analysis.
 
Sara Sperotto
No Relationships to Disclose
 
Giacomo Di Paolo
No Relationships to Disclose
 
Federico Nichetti
Honoraria - AstraZeneca
Travel, Accommodations, Expenses - Accademia Nazionale Di Medicina (ACCMED); Merck
 
Mario Domenico Rizzato
Consulting or Advisory Role - MSD
Speakers' Bureau - AstraZeneca; MSD; SERVIER
Travel, Accommodations, Expenses - Roche
 
Antonio De Rosa
No Relationships to Disclose
 
Giovanna Vitale
No Relationships to Disclose
 
Martina Bosa
No Relationships to Disclose
 
Sara Baldan
No Relationships to Disclose
 
Maital Bolshinsky
No Relationships to Disclose
 
Antonella Galiano
No Relationships to Disclose
 
Selma Ahcene Djaballah
No Relationships to Disclose
 
Caterina Soldà
No Relationships to Disclose
 
Federica Buggin
No Relationships to Disclose
 
Francesca Bergamo
Consulting or Advisory Role - Advanced Accelerator Applications/Novartis; Takeda; Teysuno
Speakers' Bureau - AstraZeneca; Bayer; BMS; Lilly; MSD Oncology; Pierre Fabre
Travel, Accommodations, Expenses - Advanced Accelerator Applications/Novartis
 
Sara Lonardi
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bayer; Beigene; Bristol-Myers Squibb; Daiichi Sankyo; Fosun Pharma; GlaxoSmithKline; Incyte; Lilly; Merck Serono; MSD; Nimbus Therapeutics; Rottapharm Biotech; SERVIER; Takeda
Speakers' Bureau - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Incyte; Lilly; Merck Serono; MSD Oncology; Pierre Fabre; Roche; Servier
Research Funding - Amgen; AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Lilly (Inst); Merck Serono; Roche (Inst)
 
Letizia Procaccio
Travel, Accommodations, Expenses - AstraZeneca